FDA expands use of Xarelto to treat, reduce recurrence of blood clots
The US Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment.
Blocked Blood Flow in Kidney Disease
If your kidneys are damaged, you may start to have health problems in other parts of your body. As rates of kidney disease rise, researchers want to know what these health problems may be.
Blocked Blood Vessels in RA
If you have rheumatoid arthritis, you may be at risk of health problems throughout your body. Even if you've never been hospitalized, you and your doctor need to closely watch for signs of complications.
Heart Diagnostic Test Recalled
A testing system commonly used to diagnose heart problems and other medical conditions has been recalled by the U.S. Food and Drug Administration.
Nano Clot-Buster Targets Blockage
Clot-busting drug tissue plasminogen activator ( tPA ) is the only approved treatment for dissolving blood clots common during stroke, heart attacks or pulmonary embolisms.
FDA Delays Blood Thinner Eliquis Again
United States Food and Drug Administration officials today delayed approval of Eliquis ( apixaban ) to prevent stroke or systemic embolism in patients with a common heart arrhythmia for the second time.
Procedure Doesn't Lower Pulmonary Embolism Mortality
Filters used to block blood clots from passing to the lungs and creating a potentially life-threatening pulmonary embolism can save patient lives. Yet a trio of new studies suggests they don't reduce the risk of dying. The vena cava filters may reduce the risk of mortality in patients considered "unstable" when they arrive at the hospital, however. Always ask about the benefits and risks of potential therapies. Paul Stein, MD, a lead researcher, professor in osteopathic medical specialties at Michigan State University and director of research at St. Mary Mercy Hospital, noted t...
Aspirin Cuts Blood Clot Risk
Following a blood clot patients commonly take warfarin (Coumadin) to prevent a recurrence. It may be just as safe and effective for those individuals to later switch to aspirin.
FDA Rejects Rivaroxaban for ACS
Following a close vote, a U.S. Food and Drug Administration panel has declined to recommend r ivaroxaban ( Xarelto ) to treat acute coronary syndrome.
Risk High During Temporary Anticoagulant Halts
Patients with certain types of atrial fibrillation, a common heart arrhythmia, are at a high risk of stroke and blood clots if they temporarily stop their blood thinning medication before surgery or permanently because of side effects.